Literature DB >> 11731180

Hormone replacement therapy: the benefits in tailoring the regimen and dose.

M Gambacciani1, A R Genazzani.   

Abstract

Despite the clear benefits of long-term hormone replacement therapy (HRT), the majority of patients tend to undergo short-term treatment. The cyclical bleedings induced by the sequential progestogen administration are often unacceptable namely in the elderly postmenopausal women. At the standard doses HRT preparations can also induce annoying hormone-related side effects, both in sequential and continuous combined regimens. Lower HRT schedules are reported to be highly effective in the relief of climacteric symptoms, inducing minimal endometrial stimulation with high rates of amenorrhea. Continuous administration of low doses of progestins is safe for endometrium protection and minimizes progestin-related side effects. Indeed, it has been demonstrated that low dose HRT can prevent the increase in bone turnover and the consequent bone loss in postmenopausal women. The choice of lower HRT dosages can also be useful for the number of potential disadvantages of standard HRT doses, mainly for long-term treatments. Low dose regimens should be considered as a starting dose to minimize the occurrence of side effects, improving compliance and, therefore, HRT effects on the prevention of long-term consequences of estrogen deprivation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731180     DOI: 10.1016/s0378-5122(01)00281-x

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  5 in total

1.  Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.

Authors:  V Camozzi; F Lumachi; F Mantero; M Piccolo; G Luisetto
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

2.  Revisiting estrogen: efficacy and safety for postmenopausal bone health.

Authors:  Sandra M Sacco; Wendy E Ward
Journal:  J Osteoporos       Date:  2010-06-22

Review 3.  Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life.

Authors:  Marius Jan van der Mooren; Peter Kenemans
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.

Authors:  Ayesha A Javed; Alexandra J Mayhew; Alison K Shea; Parminder Raina
Journal:  JAMA Netw Open       Date:  2019-08-02

Review 5.  New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women.

Authors:  Marco Gambacciani
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.